[In vitro efficacy of Ingavirin against the pandemic influenza virus A(H1N1/09)v].

Autor: Shishkina LN, Nebol'sin VE, Kabanov AS, Skarnovich MO, Erdyneeva UB, Mazurkova NA, Serova OA, Stavskiĭ EA, Drozdov IG
Jazyk: ruština
Zdroj: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2010; Vol. 55 (3-4), pp. 12-6.
Abstrakt: Ingavirin was shown to be efficient in inhibition of the influenza virus strains A/California/04/2009 (H1N1)v, A/California/07/2009 (H1N1)v, A/Moscow/225/2009 (H1N1)v and A/Moscow/226/2009 (H1N1)v, as well as the strains A/Chicken/Kurgan/05/2005 (H5N1) and A/Aichi/2/68 (H3N2) in the MDCK cell culture. The hemagglutinin and cytopathic activity of the influenza virus strains decreased at entering Ingavirin in vitro.
Databáze: MEDLINE